NCT06654778

Brief Summary

the aim of this prospective randomized blinded clinical study will be to assess the ultrasound evaluation of different preventive measures of post operative lung atelectasis in abdominal surgeries; these measures include ventilation and fluid measures

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 23, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

December 8, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2025

Completed
Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

October 20, 2024

Last Update Submit

December 19, 2025

Conditions

Keywords

lung ultrasoundlung AtelectasisAtelectasisPulmonary Atelectasispressure controlled ventilation - volume guarantee (PCV- VG)positive end-expiratory pressure (PEEP)lung recruitment maneuverrestrictive fluid strategies

Outcome Measures

Primary Outcomes (1)

  • Lung ultrasound assessment of postoperative pulmonary atelectasis at the end of surgery

    Lung ultrasound assessment of postoperative pulmonary atelectasis at the end of surgery. The Lung Ultrasound Score (LUS): the key points based on ultrasound findings: I. 0 points: (N) Normal aeration (presence of lung sliding with A-lines or \<2 separate B-lines). II. 1 point: (B1) Moderate loss of lung aeration (≥3 well-defined B lines). III. 2 points: (B2) Severe loss of lung aeration (coalescing B-lines). IV. 3 points: (C) Complete loss of lung aeration (pulmonary consolidations). Total Score: points will be distributed according to the worst ultrasound pattern observed: N = 0, B1 lines = 1, B2 lines = 2, C = 3. The LUS score ranging between 0 and 36 was calculated as the sum of points.

    at the end of surgery before emergence from GA.

Secondary Outcomes (7)

  • Lung ultrasound assessment

    before induction of general anesthesia

  • Lung ultrasound assessment

    5 minutes post induction of general anesthesia

  • Lung ultrasound assessment

    15 minutes after patients arrive to PACU

  • Lung ultrasound assessment

    60 minutes after patients arrive to PACU

  • arterial blood gases

    5 minutes post induction of general anesthesia

  • +2 more secondary outcomes

Study Arms (3)

Group I: PEEP

EXPERIMENTAL

Patients will be ventilated with PEEP of 8 cm H2O and fluid management: 500 ml of Ringer's lactate in the recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery.

Other: PEEP

Group II: PEEP/RM

EXPERIMENTAL

Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and fluid management: 500 ml of Ringer's lactate in recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery

Other: PEEP/RM

Group III: PEEP/RM/RF

EXPERIMENTAL

Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and restrictive fluid management (RF). Ringer's lactate at a rate of 3 mL/kg/hour from the beginning to the end of the surgery

Other: PEEP/RM/RF

Interventions

PEEPOTHER

Patients will be ventilated with PEEP of 8 cm H2O and fluid management: 500 ml of Ringer's lactate in the recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery.

Group I: PEEP
PEEP/RMOTHER

Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and fluid management: 500 ml of Ringer's lactate in recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery

Group II: PEEP/RM

Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and restrictive fluid management (RF). Ringer's lactate at a rate of 3 mL/kg/hour from the beginning to the end of the surgery

Group III: PEEP/RM/RF

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA physical status I or II, of either gender.
  • BMI \< 40
  • Age 30-60 years
  • scheduled for elective abdominal surgeries

You may not qualify if:

  • Patient refusal
  • American Society of Anesthesiologists (ASA) physical status classification system more than II
  • BMI \> 40 .
  • Psychiatric disorders
  • History of chest disorders such as asthma and obstructive pulmonary disease (COPD).
  • History of Previous Thoracic Procedures.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Azhar university

Asyut, Egypt

Location

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Hamed M Wally Allah

    Al-Azhar University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The patients will be assigned into three equal groups of 20 patients each: 1. Group I: PEEP of 8 cm H2O and fluid management: 500 ml + 4 mL/kg/hour Ringer's lactate 2. Group II: PEEP/RM group, addition of RM (30 cm H2O for 30 s) 3. Group III: PEEP/RM group and restricted fluid management 3 mL/kg/hour Ringer's lactate A total sample size of 60 patients will be involved.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer in Anesthesia, Intensive Care and pain management department, Faculty of Medicine, Al-Azhar University (Assiut)

Study Record Dates

First Submitted

October 20, 2024

First Posted

October 23, 2024

Study Start

December 8, 2024

Primary Completion

December 19, 2025

Study Completion

December 19, 2025

Last Updated

December 26, 2025

Record last verified: 2025-12

Locations